AMY TEH
Arrowpoint Investment Partners (singapore) Pte. Ltd.
Assets Managed
$112.515M
Holdings
81
Last Quarter
2026 - Q1
Filed Date
1mo 16d ago
Growth Rate
-83.42%(2Q avg: 247.38%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Arrowpoint Investment Partners (singapore) Pte. Ltd.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 81 positions.
Assets under management
The assets under management (AUM) of Arrowpoint Investment Partners (singapore) Pte. Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 112.515M in assets, with a quarterly growth rate of -83.42% and a 2-quarter average growth rate of 247.38%. The portfolio is managed by AMY TEH, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
IGV Ishares Expanded Tech-softwa
| 16.43% | $18.476M↑ Call 230,800 shares@ $80.05 avg price | New Position |
KWEB Kraneshares Csi China Intern
| 10.12% | $11.383M 400,400 shares@ $28.43 avg price | Increased 431.04% |
GOOGL Alphabet Inc-cl A
| 7.96% | $8.951M 31,127 shares@ $287.56 avg price | Increased 2123.36% |
SMH Vaneck Semiconductor Etf
| 7.5% | $8.432M↓ Put 22,000 shares@ $383.27 avg price | New Position |
EWZ Ishares Msci Brazil Etf
| 4.1% | $4.607M↑ Call 120,000 shares@ $38.39 avg price | New Position |
ASX Ase Technology Holding -adr
| 3.46% | $3.892M 179,512 shares@ $21.68 avg price | New Position |
IONS Ionis Pharmaceuticals Inc
| 2.61% | $2.928M 38,988 shares@ $75.1 avg price | Increased 55.85% |
NBIX Neurocrine Biosciences Inc
| 2.53% | $2.84M 21,556 shares@ $131.74 avg price | Increased 512.91% |
AXSM Axsome Therapeutics Inc
| 2.47% | $2.772M 16,401 shares@ $169.02 avg price | Increased 677.3% |
BMRN Biomarin Pharmaceutical Inc
| 2.45% | $2.752M 48,719 shares@ $56.49 avg price | New Position |
1-10 of 81